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ABSTRACT
Human embryonic stem cells (hESC) hold great promise
for the treatment of patients with many neurodegenerative
diseases particularly those arising from cell loss or neural
dysfunction including spinal cord injury. This study evalu-
ates the therapeutic effects of transplanted hESC-derived
oligodendrocyte progenitors (OPC) and/or motoneuron
progenitors (MP) on axonal remyelination and functional
recovery of adult rats after complete spinal cord transec-
tion. OPC and/or MP were grafted into the site of injury
in the acute phase. Based on Basso-Beattie-Bresnahan
scores recovery of locomotor function was signiﬁcantly
enhanced in rats treated with OPC and/or MP when com-
pared with control animals. When transplanted into the
spinal cord immediately after complete transection, OPC
and MP survived, migrated, and differentiated into
mature oligodendrocytes and neurons showing in vivo
electrophysiological activity. Taken together, these results
indicate that OPC and MP derived from hESC could be a
useful therapeutic strategy to repair injured spinal cord.
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INTRODUCTION
Spinal cord transection, besides the loss in central control of
motor, sensory and autonomic function below the injury site,
produces limited exogenous repair and poor functional recov-
ery. The cumulative death of neurons, astroglia, and oligoden-
droglia in and around the lesion site disrupts neural circuitry
and leads to neurological dysfunction [1]. Damaged axons are
unable to grow, regenerate and to reconnect themselves with
the structures that were innervated before the injury, causing
a permanent interruption of the injured nervous route [1–3].
Many factors contribute to this condition including cellular
destruction, demyelination, inability to remyelinate spared
axons, and failure of axons to overcome the conduction block
by astrocyte scar [4–6]. Introducing new cells as progenitors
of motoneurons (motoneurons progenitor, MP) or oligoden-
drocyte progenitor cells (OPC) into a damaged spinal cord to
treat a disease could be a good strategy to establish disrupted
synaptic connections between the central nervous system
(CNS) functions above and below the lesion.
Compared with other stem cell types, human embryonic
stem cells (hESC) and induced pluripotency stem (IPS) cells
currently show the greatest potential for differentiation and
cell replacement therapies. These cells are pluripotent and can
give rise to cells of three germinal layers, they can be propa-
gated indeﬁnitely in culture and can provide a large quantity
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STEM CELLS 2010;28:1541–1549 www.StemCells.comof differentiated cells for transplantation including speciﬁc
cells of neuronal or glial fates [7–14].
Recently, few studies have demonstrated that transplanta-
tion of OPC derived from hESC and MPs derived from mouse
embryonic stem cells (mESC) can provide both trophic support
for spared axons and participate in remyelination of the injured
spinal cord [15–18]. The use of hESC-derived neural progeni-
tors for treatment of spinal cord injury (SCI) has been
described [10, 19] in which authors showed that transplanted
hESC-OPC survived, integrated, differentiated, and remyelated
damaged tissue resulting in a signiﬁcant improvement of loco-
motor function of rats with spinal cord contusions. However,
there is no study that describes transplantation of hESC-OPC
and hESC-MP using an animal model with complete spinal
cord transection. Therefore, in this study, we sought to evaluate
the behavior and efﬁciency of grafted hESC-OPC and/or
hESC-MP into female rats after spinal cord transection.
MATERIALS AND METHODS
Cell Culture and Differentiation
Primary hESC colonies (H9, H9-green ﬂuorescent protein (GFP)
and H1 lines, WiCell Inc., Madison, WI) were mechanically dis-
persed into several small clumps, which were cultured on fresh
commercially available human foreskin ﬁbroblasts (American
Type Culture Collection, Manassas, VA, USA), inactivated by
mitomycin C in ES medium containing Knockout-Dulbecco’s
Modiﬁed Eagle Medium (DMEM) (Invitrogen, Carlsbad, CA,
http://www.inivitrogen.com), 100 lM ß-mercaptoethanol (Sigma,
St. Louis, http://www.sigmaaldrich.com), 1 mM L-glutamine
(Invitrogen), 100 mM nonessential amino acids, 20% serum
replacement (SR; Invitrogen), 1% penicillin-streptomycin (Invi-
trogen), and 8 ng/ml basic ﬁbroblast growth factor (bFGF; Invi-
trogen). Embryonic stem cell (ESC) medium was changed every
second day. Human ESC were passaged by incubation in 1 mg/
ml collagenase IV (animal-free, Invitrogen) for 5–8 minutes at
37 C or mechanically dissociated and then moved to freshly pre-
pared human foreskin ﬁbroblast layer.
Cells were differentiated toward OPC according to already pub-
lished protocols [10, 19] (Fig. 1). Brieﬂy, cell clumps were placed
for 2 days in 50% hESC growth media and 50% glial restriction
media (GRM) [10] in ultralow attachment six-well plates (Corning,
NY, USA, http://www.corning.com). This medium was then
replaced with 100% GRM supplemented with 20 ng/ml epidermal
growth factor (EGF; Sigma-Aldrich) and 10 lM/ml all-trans-reti-
noic acid (RA) in dimethyl sulfoxide (DMSO) for an additional 7
days. During 25 days the cells were exposed to GRM supplemented
with 20 ng/ml EGF. Then, ﬂoating yellow spheres were plated in
six-well plates (BD, Franklin Lakes, NJ, USA, http://www.bd.com)
1:30 Matrigel for 1 week. The progenitors were migrated from
spheres. Cell cultures were then replated on 1:30 Matrigel substrate
a n dc u l t u r e df o r1w e e ki nG R Ms u p p l e m e n t e dw i t h2 0n g / m lE G F .
The duration of the protocol was 42 days. At this point the cells
were ready for transplantation. For transplantation, the cells were
disaggregated mechanically using a glass pipette.
For motoneuron differentiation, we used modiﬁed protocol of
Li et al. [12]. Brieﬂy, the H9 cell line was permanently trans-
fected with plasmid carrying GFP (H9-GFP). Cell clumps were
placed in normal hESC medium for 4 days without bFGF to form
embryoid bodies (EB) in ultralow attachment six-well plates
(Corning). The medium was changed daily. Then the EB were
placed in normal six-well plates on 1:30 Matrigel substrate to
attach in motor induction medium (MIM) composed of
DMEM:F12 with Glutamax, N2 supplement, heparin (2 lg/mL),
and bFGF (20 ng/mL). After 1 day, EB attached and after 4 days
rosettes start to appear. From day 8, 0.1 lM all-trans-RA was
applied in MIM. The medium with RA was changed daily. At
day 16, the rosettes were mechanically cut and placed in ultralow
attachment six-well plates as round structure-neuromasses in
motor medium (MM) consisting of neurobasal medium, N2 sup-
plement, 1 lM cAMP, 0.1 lM RA, and supplemented with 200
ng/mL sonic hedgehog (SHH; R&D Systems Minneapolis, MN,
USA, http://www.RnDSystems.com) for 7 days. The neuromasses
were maintained in MM medium supplemented with SHH (50
ng/ml) until the day of transplantation. At the day of transplanta-
tion, these neuromass-like structures were disaggregated mechani-
cally with a glass pipette. This is the stage when the early MPs
(ISL1þ and Tuj1þ) start to mature [12].
Experimental Groups
To determine whether OPC and/or eGFP-expressing MP are ca-
pable to improve motor function when immediately transplanted
after SCI,  1.5 million cells were transplanted into the spinal cord
in the acute phase after a complete transection of the spinal cord
at the thoracic level [20, 21]. Fourteen rats per group were used.
Three different transplantation experiments were performed: the
rats were treated with a single cell type (OPC; n ¼ 14 or MP; n
¼ 14) or in combination (OPC þ MP; n ¼ 14) and each was fol-
lowed after transplantation for immunohistochemical evidence of
cell incorporation in the lesion site and their survival. We per-
formed electrophysiological and behavioral studies of functional re-
covery from hindlimb paralysis. We, therefore, deﬁned ﬁve groups
of animals, including sham and controls (n ¼ 14). Acute transplan-
tation controls included animals that received vehicle-only injec-
tions. For more details of surgery procedure and other methods
used in this study please see Supporting Information.
Behavioral Assessment
Functional recovery was assessed by evaluators blinded to treat-
ment groups. Open ﬁeld locomotor test using the Basso-Beattie-
Bresnahan (BBB) locomotor rating scale [22] was performed in a
plastic tray (50   80   40). One week before injury, each animal
was acclimated to the open ﬁeld and scored. The BBB test was
performed every week after injury during 4 months when two inde-
pendent examiners observed and recorded, with video digital cam-
era (Sony), the hindlimb movement of the rats, which range from
0 (no hind movement) to 21 (normal gait). The videos were ana-
lyzed frame by frame using ImageMixer 3SE software and scored
independently by two observers blinded to the treatment group.
Electrophysiology Measurements In Vivo
The motor potentials were evoked and recorded according to a
prior study [23]. The main difference in our study was that the
cranial screw was not implanted and a needle electrode was used.
According to the anesthetics study of Oria et al. [24], the protocol
was administered intravenously as a bolus dose of 10 mg/kg. For
the recording of evoked potential (motor-evoked potential [MEP]
and compound motor action potential [CMAP]) one needle elec-
trode was placed in the tibialis anterior muscle (cathode) and
one-needle electrode subcutaneously at the foot pad level (anode).
For the induction of CMAP following peripheral nerve stimula-
tion, one electrode was placed in the muscle (cathode) and
another subcutaneously (anode), both near the sciatic nerve. For
the induction of MEP (after central stimulation), one-needle elec-
trode was placed subcutaneously at the level of the lower jaw
(anode) and a needle electrode (cranial level) was used for the
cathode. For ground, an electrode was placed subcutaneously in
the lumbar region. The electrophysiological recordings were per-
formed with an electromyographer (Medtronic Keypoint Portable,
Denmark) and the bandpass used was 2 Hz to 10 KHz. Through-
out the experiments, the duration of the pulse was 0.1 ms. The
recordings were started by measuring the maximum amplitude of
the CMAP. This was achieved by stimulating the sciatic nerve
with a single pulse of supramaximal intensity. To induce MEP, a
stimulation of 25 mA intensity was applied at the needle elec-
trode (cranial level). Results were expressed as latency (ms) and
amplitude (%) (MEP/CMAP ratio).
1542 Locomotor Recovery After Spinal Cord TransectionFigure 1. hESCs were differentiated toward OPC in hESC growth media and glial restriction media (GRM) supplemented with EGF and all-trans-
RA. During 25 days, the EBs were exposed to GRM supplemented with EGF. Floating yellow spheres were plated for 1 week. Cell cultures were
replated on Matrigel substrate, and cultured for 1 week in GRM supplemented with EGF. The duration of the protocol was 42 days. For transplanta-
tion, the cells were disaggregated mechanically using a glass pipette. For motoneuron differentiation, hESC were permanently transfected with a plas-
mid carrying GFP. Cell clumps were grown for an additional 4 days to form EBs. The EB were placed on a Matrigel substrate to attach in motor
induction medium. From day 8, RA was added. At day 16 the rosettes were placed as round structure-neuromasses in MM consisting of neurobasal
medium, N2 supplement, cyclic AMP (cAMP), RA, and SHH. The neuromasses were maintained in MM medium supplemented with SHH until the
day of transplantation. Differentiated cells were characterized and  1.5 million cells were transplanted. Three different transplantation experiments
were performed: The rats that were treated with a single-cell type (OPC or MP) or in combination (OPC þ MP). Immunohistochemical evidence of
cell incorporation in the LS, and electrophysiological and behavioral studies were performed after 4 months. Abbreviations: bFGF, basic ﬁbroblast
growth factor; EB, embryoid body; EGF, epidermal growth factor; GFAP, glial ﬁbrillary acidic protein; GFP, green ﬂuorescent protein; hESC, human
embryonic stem cell; MBP, myelin basic protein; MP, motoneuron progenitor; OPC, oligodendrocyte progenitors; RA, retinoic acid; RIP, receptor
interacting protein; SHH, sonic hedgehog.Statistical Methods
BBB scores were analyzed by repeated measures two-way
ANOVA with Bonferroni multiple comparison test at each time
point. The differences were signiﬁcant when p < .05.
RESULTS
The experimental procedure including differentiation and cell
transplantation is presented in Figure 1. Characterization of
hESC-OPC and hESC-MP used for cell transplantation is pre-
sented in Supporting Information (Supporting Information
Figs. 1 and 2).
Animals
The majority (80%) of animals survived following injury.
Some animals died due to ulcers, autophagia, or considerable
weight loss 1 month after surgery. There was a loss of about
10%–20% in animal body weight (data not shown) during the
ﬁrst month, but the animals recovered following 4 months
postinjury. No formation of teratoma was observed 120 days
after cell transplantation. Complete spinal cord transection
lesion was characterized by an obvious traverse scar at the T8
lesion epicenters and neuronal necrosis and cavitations rostral
and caudal (below and above) the lesion site (Supporting In-
formation Fig. 3A–E). The transaction site was characterized
by the presence of the white tissue between cord stumps. Re-
active gliosis was detected by immunohistochemistry using
anti-GFAP. These results conﬁrmed that as a consequence of
the transection of spinal cord, abundant loss of oligodendro-
cytes [25] occurred at considerable distance from the lesion.
Transplanted Cells Survived, Migrated, and
Differentiated Within the Spinal Cord
A total of 1.5 million cells were transplanted rostrally and
caudally to the lesion site at T8 in 5- to 7-week-old female
rats in the acute phase of SCI. We speciﬁcally tested three
transplantation strategies including control and sham groups.
The ﬁrst group included rats transplanted with GFP-expressed
MP (MP group). In the second group of animals, OPCs previ-
ously labeled with Hoechst were transplanted (OPC group). In
the third group of rats, equal quantity of OPCs was given,
previously labeled with Hoechst and GFP-expressing MP
(OPC þ MP group). In all animals, including the control ani-
mals, we administered subcutaneously the phosphodiesterase
type 4 inhibitor (Rolipram), an axonal growth supporter [15].
Four months after lesion, control animals treated with or with-
out Rolipram showed only scattered neuroﬁlament (NF)-posi-
tive ﬁbers in the central scar. Many NF-immunoreactive ﬁbers
were stopped at the host-scar interface (Fig. 2A). Rolipram
did not dramatically increase amounts of NF-positive ﬁbers in
control rats compared with the rats without Rolipram, in ac-
cordance with behavioral tests (see below). The survival of
the transplanted cell was less than 1% (Supporting Informa-
tion Fig. 4). The lesion site of control rats without transplants
was negative for anti-human nuclei staining, GFP ﬂuorescence
and NF70 (data not shown).
MP Group
Either GFP-expressing MP or MP, previously dissociated,
were injected into the rostral and caudal areas 1–2 mm away
from the center of injury to avoid central cavitation. Surviving
mature MP-derived GFP cells were observed within the gray
matter of the spinal cord (Fig. 2C–2G). Four months after
transplantation, GFP-labeled MPs were visualized as a dense
mass of elongated, brightly ﬂuorescent cells extending from
the lesion site (Fig. 2C). These MP-derived neurons persis-
tently expressed GFP, which conﬁrmed that MPs were capa-
ble of surviving and engrafting for at least 4 months after
transplantation (Supporting Information Fig. 4). Most of the
cells in the lesion were immunoreactive for glial ﬁbrillary
acidic protein (GFAP) (Fig. 2B, 2C; 46% 6 6% of GFP
þ).
The MPs were gathered in the lesion gap, which was sur-
rounded by an intensively GFAP-positive border of reactive
astrocytes reaching 4 mm caudal and 5 mm cranial. GFP and
NF70 immunostaining (the lesion samples injected with MP)
suggests that these cells differentiated toward neurons in the
glial scar (Fig. 2E, 2F; 11% 6 2% of GFP
þ cells). The phe-
notype of these neurons remains unknown as these GFP neu-
rons were neither interneurons (Pax2
  neurons) nor motoneur-
ons (HB9
 ) 4 months after transplantation (data not shown).
Many GFP
þ cells coexpressed oligodendrocyte markers O4 or
NG2 (Fig. 2D, 2G; 36% 6 8% of GFP
þ cells). An additional
proof of dual terminal differentiation of hESC-derived MP is
the presence of GFP
þ cells surrounding NF70
þ ﬁlaments
(Fig. 2F) that suggests that transplanted cells also have the
capacity to mature to oligodendrocytes.
OPC Group
Transplanted OPC previously labeled with Hoechst survived
and migrated over short distances of the spinal cord during
the postimplantation survival period in all treated animals
(Fig. 2). Most of the human nuclei positive cells were located
in the lesion site (Fig. 2I; Supporting Information Fig. 4).
Double staining to human nuclei and GFAP or O4 revealed
that the majority of transplanted cells differentiated to astro-
cytes and oligodendrocytes in the lesion site (Fig. 2I, 2L;
28% 6 3%, 45% 6 6%, respectively). Interestingly, immuno-
histochemical analysis revealed NF70
þ ﬁbers in the lesion
site suggesting that human OPC also differentiated toward
neuronal cells (Fig. 1H, 1J, 1M; 23% 6 4%) often in close
association with NG2
þ cells (Fig. 2H). Speciﬁcity of NF70
antibody to human neurons conﬁrms human origin of these
cells. Curiously, many adematous polyposis coli (APC)
þ cells
were observed providing myelin sheet to those NF70
þ ﬁbers
(Fig. 2K) suggesting that a considerable number of OPC-
transplanted cells differentiated toward neurons and oligoden-
drocytes (Fig. 1). The NF70
þ ﬁbers were localized only in
the lesion site and  2 mm rostrally and 3 mm caudally, sug-
gesting that observed neuronal cells were not motoneurons
(Fig. 2A; Supporting Information Fig. 4). Many NF70
þ cells
colocalized with PAX2 (Fig. 2J) suggesting the interneuron
nature of differentiated neurons. These observations corrobo-
rate with reverse transcription polymerase chain reaction (RT-
PCR) analysis of OPC used in transplantation, where we
revealed expression of NF and bIII-tubulin (TUJ1
þ) charac-
teristic for neuronal progenitors (Supporting Information Fig.
5).
OPC 1 MP Group
For the OPC þ MP group, we obtained the same immunohis-
tological results regarding the OPC cells and MP. Trans-
planted cells differentiated to mature oligodendrocytes as con-
ﬁrmed by staining of spinal cord sections for the
oligodendroglial markers. Clusters of GFP
þ cells were dou-
ble-labeled with both NG2 (Fig. 3A–3C) and APC (Fig. 3D).
Detection of APC-CC1-positive cells negative for antihuman
nuclear antigen reveals the possible endogenous origin of
these cells.
The GFP-positive axons, double-labeled with NF70, were
found in OPC þ MP transplanted rats (Fig. 2E–2I). NF-
1544 Locomotor Recovery After Spinal Cord Transectionpositive axons were often found in bundles (Fig. 3E–3G, 3I)
and exceeded the number of GFP
þ cells, thus conﬁrming their
OPC origin.
RT-PCR of the Spinal Tissue
To ensure that the functional recovery was caused by trans-
planted human cells we isolated total RNA from the lesion
Figure 2. Acute transplantation of human embryonic stem cell-derived OPC or MP resulted in differentiation toward oligodendrocytes and neu-
rons. (A): The neuronal ﬁbers (NF200
þ) were stopped at host-scar interface in control (nontransplanted) animals. (B): Neuronal ﬁbers positive
for human-speciﬁc NF70
þ (green) were detected in the lesion site surrounded with glial GFAP
þ cells in MP-transplanted animals. In the lesion
of the GFP-MP treated animals many GFP
þ cells were double-labeled with glial GFAP (C) and oligodendrocyte (NG2) markers ([D], marked as
‘‘*’’). Dual fates of the transplanted MP were conﬁrmed with double labeling of the GFP (marked as ‘‘*’’) and NF70 (red; arrow; [E] and [F])
surrounded by oligodendrocytes (G) (marked as ‘‘*’’). In the lesion site of the OPC-transplanted animals, human-speciﬁc neurons were observed
because the cells were positive for NF70 ([H]; marked as ‘‘*’’). The majority of the cells in the lesion site were astrocytes, GFAP
þ (green), and
oligodendrocytes O4
þ (red; [I]; marked as ‘‘*’’). (J): Many cells were positive for the human-speciﬁc neuronal marker NF70 and interneuronal
marker PAX2 (marked as ‘‘*’’). (K): In the lesion site, we observed myelination of transplanted cells. The NF70
þ ﬁbers (marked as arrow) were
surrounded with oligodendrocytes (APC
þ, marked as ‘‘*’’). (L): The majority of the cells were oligodendrocytes and double-labeled with NG2
and hNU (marked as ‘‘*’’). (M): Many NF
þ ﬁbers were localized only in the lesion site with GFAP
þ cells. Observations: (B): Immunoﬂoures-
cence was done with the spinal cord samples, where MP (without GFP) were injected. Abbreviations: APC, adematous polyposis coli; GFAP,
glial ﬁbrillary acidic protein; GFP, green ﬂuorescent protein; LS, lesion site; MP, motoneuron progenitors; OPC, oligodendrocyte progenitors.
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www.StemCells.comsite and converted this to cDNA 4 months after transplanta-
tion. We found the expression of human GAPDH, GFAP,
NG2, TUJ1, and MAP2 but not in the control rats or nonle-
sioned part of the spinal cord (Supporting Information Fig. 5)
conﬁrming the presence of differentiated hESC. These cells
ﬁnally matured to astrocytes, oligodendrocytes, and neurons
(expressing GFAP, NG2, and TUJ1, respectively; Supporting
Information Fig. 5) but only OPC and OPC þ MP expressed
human MAP2 (marker for postmitotic neurons), which is an
additional proof of a triple fate of OPC and MP.
Behavioral Assessment
Hindlimb motor function was assessed using the BBB loco-
motor rating scale [22, 26]. The behavioral results (Fig. 4E)
were collected by weekly BBB tests during the 4-month mon-
itoring period for each group of animals. Before the injury,
all animals showed normal locomotor activity, scored as 21
on the BBB scale, although all injured rats manifested com-
plete hindlimb paralysis 7 days after injury, resulting in a
score of 0. The BBB scores were in the range of 0–1 or 2 in
the control animals during the 4 months after SCI. In contrast,
MP, OPC, and OPC þ MP groups showed hindlimb func-
tional locomotor recovery that increased gradually after 3
weeks of transplantation. Four months after transplantation all
42 transplanted animals displayed BBB scores signiﬁcantly (p
< .001) higher than that achieved by the control group. OPC
animals reached a ﬁnal average BBB score of 6, which is sig-
niﬁcantly (p < .001) higher than the control group that
reached only 1.5. MP rats partially recovered hindlimb move-
ments and after 4 months reached a ﬁnal average score of 6,
signiﬁcantly higher than control animals. Also, the OPC þ
MP group regained signiﬁcantly (p < .001) more functional
recovery than the control group and versus single cell type
treatment (Fig. 4E) reaching a ﬁnal average BBB score of 9.
Signiﬁcantly higher (p < .001) BBB score in OPC þ MP
score was reached after 5 weeks of transplantation compared
with control animals and after 12 weeks compared with single
cell treatment (Fig. 4E and Supporting Information Table 1).
Electrophysiological Evaluation
Electrophysiological tests were performed in all rats before
and after the surgery and transplantation to ensure the com-
plete transection of the spinal cord. MEPs were used to evalu-
ate the function of spinal cord descending tracts [27]. Electro-
physiological tests were performed for 4 months in all
animals at monthly intervals. The electrophysiological tests
demonstrated complete interruption of spinal motor pathways
after the injury (Fig. 4A). In control animals, MEP did not
recover over time, indicating that interruption of supraspinal
axons was maintained until the end of the observation period
(Fig. 4A). In contrast, in the OPC group and/or MP group,
MEP reappeared  40 days after grafting (Fig. 4A, 4B), indi-
cating functional spinal reconnection and partial restitution of
motor pathways. Four months after injury, the amplitude of
the evoked action potentials showed recovery in OPC and/or
MP groups. Comparatively, animals that received OPC and
MP tended to show MEP of higher amplitude than those with
a single cell progenitor type treatment (Fig. 4C). Although the
rats treated with OPC showed higher amplitude after 3
months compared with other treatments, the mean amplitude
of evoked potentials after 4 months were higher, but not stat-
istically signiﬁcant (p > .05) in the OPC þ MP group com-
pared with OPC or MP (Fig. 4C) groups. Also the animals
transplanted with a single type of cells, OPC or MP, showed
shorter latency in comparison with OPC þ MP (Fig. 4D).
Figure 3. Acute transplantation of human
embryonic stem cell-derived oligodendro-
cyte progenitors (OPC) and motoneuron
progenitors (MP) resulted in differentiation
toward oligodendrocytes and neurons.
Many GFP
þ cells were observed in the
lesion site and colabeled with oligodendro-
cyte markers NG2 (A, B, C) and APC (D)
(marked as ‘‘*’’). We observed NG2
þ
(marked as ‘‘*’’) cells surrounding GFP
þ
(arrow; [E]). Many NF70
þ cells were
observed in the lesion site often localized
in bundles (G, H). All NF70
þ cells were
not GFP
þ revealing that other human neu-
rons proceed from OPC (E, F, I). Observa-
tions: (C, G): Immunoﬂourescence was
done with the spinal cord samples, where
MPs (without GFP) were injected. Abbrevi-
ations: APC, adematous polyposis coli;
GFP, green ﬂuorescent protein; LS, lesion
site.
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Our results demonstrate that acute transplantation of a single
cell progenitor type (OPC or MP) or a combination of thereof
into completely transected spinal cord promotes partial recov-
ery of hindlimb movement. As implantation of OPC in the
contusion model has been reported to promote partial func-
tional recovery following SCI [10], we focused on upgrading
this study to assess the regenerative properties of OPC and
MP derived from hESC using an animal model with complete
spinal cord transection. To our knowledge, this is the ﬁrst
study that describes cell transplantation of hESC-MP followed
by a detailed in vivo electrophysiological assay.
The ﬁrst signs of recovery in locomotor function were
observed after 3 weeks. The BBB scale showed signiﬁcant
improvement of locomotor ability when differentiated hESC
were transplanted. The behavior of control animals was consist-
ent with the results obtained using human umbilical mesenchy-
mal stem cells [28] or olfactory ensheathing cells [20]. Because
of its non-neurogenic nature, the spinal cord has a nonpermissive
environment for the generation of new neurons [29–31] and has
a limited capacity for nerve regeneration, at least in part, due to
the presence of myelin-associated inhibitors that trigger signaling
pathways that decrease intraneuronal cAMP [32]. To stimulate
axon regeneration, the inhibitory effects of myelin need to be
compensated by dibutyryl cyclic AMP (dbcAMP) and systemic
administration of Rolipram [15, 16, 33]. The effectiveness of this
phosphodiestherase inhibitor after SCI is already known [15, 34,
35] and it could attribute additionally to the neuronal growth of
transplanted cells and locomotor recovery of lesioned rats after
cell transplantation. Passive and active daily rehabilitation of
injured animals could favor the recovery. Although the mecha-
nisms by which the training could improve the performance in
lesioned rats are still unknown, training could facilitate axon
regeneration, and/or provide protection for the neurons and glia
near the injury site increasing neurotrophic factors [brain-derived
neurotrophic factor (BDNF), NT-3] and their Trk receptors in the
spinal cord [36–39].
A novelty of this study is that after spinal cord transection
OPC- and/or MP-transplanted rats showed recovery of MEP. Im-
mediately after complete transaction, MEPs disappear because of
disruption of all descending tracts. In the control group, we did not
observe MEP throughout the experiment due to the failure of
spontaneous axonal regeneration within nontransplanted spinal
cord [40]. The recoveries of MEP can be attributed to the recon-
nection of the axons above and below the lesion site and the con-
tribution of oligodendrocytes. The time of reappearance of MEP
in treated animals is associated with the stabile partial recovery
observed by BBB, suggesting that recovery of motor skills was
due to the recovery of descending control of hindlimb movements.
We determined that MP are able to mature and develop fun-
damental functions of normal motoneurons in vitro (expressing
OLIG2, ISL1,a n dHOXC5), including directional growth of long
axons, conﬁrming the results from the previous study [11]. The
BBB score of the MP group was higher than in the control group
and immunohistochemistry analysis conﬁrmed that hESC-MP
survive, migrate, and engraft for at least 120 days in the lesion
site. These data suggest that the application of ex vivo condition-
ing may allow efﬁcient generation of new neurons in non-neuro-
genic regions as it is SCI. Interestingly, the immunohistochemis-
try analysis showed clear evidence that these progenitors have
the capacity to ﬁnally differentiate to mature oligodendrocytes
and neurons in the lesion site. Our strategy did not result in the
formation of anatomically, physiologically, and functionally
active motor units between transplanted axons and host muscle,
but the fact that these cells innervate the lesion site ﬁlling the
Figure 4. In vivo electrophysiology and BBB test. (A): Representative electrophysiological recordings in control and transplanted animals dur-
ing 4 months of the experiments. (B): After  40 days, the electrophysiological signal appeared in the transplanted but not in the control animals.
Plot graphics of the evolution of amplitude (C) and latency (D). (E): Starting 4 weeks after the transplantation, a signiﬁcant increase (p < .001)
in locomotor recovery as determined by the BBB locomotor rating scale was observed in all transplanted animals compared with controls. The
values are presented as mean 6 SEM. The statistic analysis of BBB score for each time point is presented in Supporting Information Table 1.
Abbreviations: BBB, Basso-Beattie-Bresnahan locomotor rating scale; CMAP, compound motor action potential; MEP, motor-evoked potentials;
MP, motoneuron progenitors; OPC, oligodendrocyte progenitors.
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cantly improved locomotor function of lesioned rats suggests
that hESC-MP have promising regenerative potential.
Interestingly, transplanted OPC had signiﬁcant recovering
effects too. In a contusion model, even after severe contusive
SCI, surviving axons persist in the subpial rim of white matter
and restoration of the oligodendrocyte population by replacement
therapy has been considered as a potentially attractive strategy to
promote remyelination after SCI [10, 19, 41]. But in the case of
the spinal transection model there is no evidence of the presence
of spared host axons. After analysis of control rats, survival of
host axons or spontaneous regeneration was not observed. Immu-
nohistochemical analysis showed differentiation of transplanted
cells toward neuronal cells, which was conﬁrmed by the presence
of human speciﬁc NF70
þ neuroﬁlaments in the lesion site. This
result contrasts to previous claims that hESC differentiate exclu-
sively toward a pure population of OPC [10, 19]. We hypothe-
sized that the potential of OPC to recover is due to the presence
of heterogeneous cell types or multiple character of transplanted
progenitors. Analyzing the transcription phenotype of obtained
OPC at day 42, we observed strong expression of OLIG2 [42–
44], which gives rise to motoneurons during the neurogenic
phase. Nevertheless, OLIG2 is expressed in human OPC [45] and
is necessary for speciﬁcation and differentiation of human OPC
[44]. In rodents, OLIG2-expressing spinal progenitors from the
MP (pMN) domain are a source of both motoneurons and OPC
[46, 47]. pMN cells in the spinal cord initially produce motoneur-
ons, but switch later in development to form oligodendrocytes
[48–50]. It has been proposed that transplanted OPC may undergo
their last division to adapt to a new environment by responding
appropriately to environmental cues [51] (Fig. 1). Shihabuddin
et al. [29] have showed that isolated and in vitro expanded neural
progenitors from adult spinal cord (non-neurogenic zone) have
the ability to respond to epigenetic signals in vivo, after transplan-
tation, by site-speciﬁc differentiation, generating proper neurons
and/or glial cells depending on the transplantation site. Although
we can conclude the commitment of generated OPC to oligoden-
droglial fate [10, 19], neuronal cells were also observed in vitro
indicating that nearly 20% of differentiated cells were TUJ1
þ.
We believe that the presence of neuronal progenitors within trans-
planted OPC caused signiﬁcant recovery of animals. OPC could
generate a paracrine/trophic environment and positively modulate
the local immune response, as well as promote neuronal protec-
tion and activation of endogenous neurogenesis [41, 52] suggest-
ing that regenerative mechanisms do not depend exclusively on a
speciﬁc cell fate. Possible percentage of Tujþ (spontaneously
generated or not) could have origin from early neural processes.
By the way, all cells arise from the same pool of neural stem
cells, and it is not excluded that neurons arose from this pool.
Finally, the cell transplantation strategy showed similar recovery
effects that included synergic action of OPC and MP because
these two cells types formed myelin-axon interaction.
The functional locomotor recovery analysis of the rats trans-
p l a n t e dw i t hO P Ca n dM Ps h o w e ds i g n i ﬁ c a n t l yb e t t e rh i n d l i m br e -
covery than the animal groups treated with a single cell type. These
results have shown that combination of OPC and MP is superior
approach when comparing with a single type strategy used in our
study or when compared with the studies where other cell stem
types strategies used in the same rat model of SCI [20, 28, 53, 54].
As demonstrated in our results, locomotor improvement after trans-
plantation, the OPC and MP is associated with abundant presence
of human NF-positive ﬁbers and oligodendrocytes in the lesion.
That means that hESC-derived OPC and MP were able to differen-
tiate into mature oligodendrocytes and neurons. This was not the
case in our previous study where we used ependymal stem cells to
treat animals with spinal cord contusion [41].
CONCLUSION AND PERSPECTIVES
Therapeutic use of stem cells to regenerate neural cells in the
damaged spinal cord requires efﬁcient delivery of stem cells into
the injured area. The cells should differentiate into mature and
functional cells that engraft for extended periods of time. Future
studies must examine: (a) whether hESC-derived motoneurons
have the ability to extend toward anatomically and functionally
appropriate distal muscle targets; (b) whether they can form junc-
tions on reaching these muscles as previously shown using
mESC [15]; and (c) whether the functional locomotor improve-
ment can be enhanced using OPC. Therefore, the mechanisms
underlying the promotive effects on the functional recovery after
transplantation of the hESC-derived OPC and MP is rather the
ability of these cells to differentiate into neuronal and glial cells
than promotion of endogenous axonal regeneration.
Taken together, our study demonstrates that hESC-OPC
and hESC-MP, when transplanted into the spinal cord immedi-
ately after the injury, survived for at least 4 months; migrated at
least 3 mm away from the lesion; differentiated into appropriate
cell types without forming teratomas, and improved locomotor
function. These results open up new possibilities and strategies
for future clinical applications in SCI and constitute a promis-
ing approach for repairing the damaged spinal cord especially if
transplantation is shortly delayed after the lesion.
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